Search
-
VOGO and the European Handball Federation have signed a new contract
VOGO and the European Handball Federation have signed a new contract for the VOGO ELITE BUNDLE video replay solution to be used by referees in the Men’s and Women’s EHF EUROs 2024 and 2026
-
Euro-Africa Montpellier WATER DAYS
Montpellier Méditerranée Métropole, MedVallée, and the ICIREWARD UNESCO Water Centre invite you to the first edition of the Euro-Africa Montpellier Water Days on October 9 and 10, 2023.
-
Euro-Africa Montpellier Biennial
Following the success of the Africa-France Summit, Montpellier is proud to host and co-organize the first Euro-Africa Biennial in the fall of 2023. It will be a key week for bringing together the E...
-
SPECIFIC POLYMERS, 20 years supporting sustainable innovation
The SPECIFIC POLYMERS research center, celebrating its 20th anniversary on June 8 at Domaine Décalage in Saint Aunès, is taking a decisive step forward by applying its unique expertise to new energ...
-
Montpellier Métropole intensifies its international action
Montpellier Métropole is accelerating its international focus. Here’s a look at a strategy designed to increase visibility for local companies and products.
-
Montpellier BIC startups have the wind in their sails!
A new wave of success for the Montpellier Métropole startup incubator: Adagio, Axeptio, Skwad, and Sonup, four startups assisted by Montpellier BIC, are announcing new developments.
-
Montpellier and Heidelberg strengthen their business ties
The business exchange program was originally set up by the two cities’ economic development departments for local businesses, but has now been expanded with customizable export programs.
-
Medincell : historical succes in the heart of MedVallée
MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.
-
Medincell: historical success in the heart of MedVallée
MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.
-
MEDINCELL: HISTORICAL SUCCESS IN THE HEART OF MEDVALLÉE
On April 28, the pharmaceutical company MedinCell and its partner TEVA announced that the US Food and Drug Administration (FDA) approved a long-acting injectable medication for treating schizophren...
